SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MisterED who wrote (2979)12/2/1997 3:07:00 PM
From: j bayer  Read Replies (2) of 23519
 
<there is every indication that Vivus will have strong earnings
next year. >

Earnings this year were strong too and look at us. J & J doesn't care what happens to VVUS' stock price. Muse works - they know that and that's all they care about. J & J didn't get into VVUS for a return on a stock investment. We did!! I agree J & J must believe there will still be a market for Muse even after Viagra is marketed but the stock price of VVUS will suffer for a long time to come IMO. We're down today on what was long awaited good news. So the new plant gets approved and more Muse can be shipped. If the market believes the demand for Muse will be limited by Viagra, VVUS' ability to make more of a product that has a lowered demand may not do a damn thing for the stock even in the longrun. I'm getting very discouraged. I won't sell, as a matter of fact I bought more yest. @ 23.37. Waiting for that big PR push. Maybe that will help. Something has to.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext